Delivery Order SPE2DB20D2014-SPE2DB25FB28A

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,264.40 Firm Fixed Price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has a completion date of February 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.66 firm-fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of April 10, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,473.80, is for the delivery of the PEDIARIX 0.5 ML SYRINGE 0.5ML vaccine product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,970.96 Firm Fixed Price Delivery Order contract is for the provision of 0.5 ML PEDIARIX syringes, a pediatric vaccine. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,319.30 firm-fixed-price delivery order is for the supply of 0.5 mL syringes of the PEDIARIX vaccine. The award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,332.30 firm fixed-price delivery order contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,319.80 firm fixed-price delivery order is for the supply of 0.5 mL syringes of the PEDIARIX vaccine, with a period of performance through July 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,032.14 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a medical product used for pediatric vaccination. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,912.52 firm fixed price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,681.24, is a Firm Fixed Price Delivery Order for the supply of 0.5 ML PEDIARIX syringes. The award has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB28A
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,217.43 firm fixed-price delivery order is for the supply of 0.5 mL syringes of the PEDIARIX vaccine. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/9/25, 9:46 AM